Figure 5.
Figure 5. CML neutrophils confer growth advantage to CML cells. Mixtures of 105 normal (HLA-A2) and CML (HLA-A2-) CD34+ cells were cultured in 2 mL serum-free medium supplemented with 10 ng/mL G-CSF, GM-CSF, and SCF in the presence of varying concentrations of CML neutrophils. After 8 days of culture, nucleated cells were counted, harvested, and analyzed for the percentage expression of HLA-A2. (A) Percentage and (B) absolute number of HLA-A2-positive (normal) and HLA-A2- (CML) cells in the presence of increasing numbers of CML neutrophils (▪, HLA-A2+ cells; □, HLA-A2- cells). (C) Percentage and (D) absolute number of HLA-A2+ (normal) and -negative (CML) cells in the presence of CML neutrophils and protease inhibitor (▪, HLA-A2+ cells; □, HLA-A2-). (E) Percentage inhibition induced by CML neutrophils. Data represent mean ± SEM of 3 experiments (•, normal CD34+ cells; ○, CML CD34+ cells). *Indicates significant differences from normal values (*P < .05).

CML neutrophils confer growth advantage to CML cells. Mixtures of 105 normal (HLA-A2) and CML (HLA-A2-) CD34+ cells were cultured in 2 mL serum-free medium supplemented with 10 ng/mL G-CSF, GM-CSF, and SCF in the presence of varying concentrations of CML neutrophils. After 8 days of culture, nucleated cells were counted, harvested, and analyzed for the percentage expression of HLA-A2. (A) Percentage and (B) absolute number of HLA-A2-positive (normal) and HLA-A2- (CML) cells in the presence of increasing numbers of CML neutrophils (▪, HLA-A2+ cells; □, HLA-A2- cells). (C) Percentage and (D) absolute number of HLA-A2+ (normal) and -negative (CML) cells in the presence of CML neutrophils and protease inhibitor (▪, HLA-A2+ cells; □, HLA-A2-). (E) Percentage inhibition induced by CML neutrophils. Data represent mean ± SEM of 3 experiments (•, normal CD34+ cells; ○, CML CD34+ cells). *Indicates significant differences from normal values (*P < .05).

Close Modal

or Create an Account

Close Modal
Close Modal